ERICA WILLIAMS: Open Payments
NPI 1164207593 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,930 in 109 payments from 16 companies in 2025. Trend: 2023 $317 · 2024 $3,322 · 2025 $2,930
Food & beverage: $2,930
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $750 |
| Madrigal Pharmaceuticals | 16 | $551 |
| Janssen Biotech, Inc. | 14 | $393 |
| GENZYME CORPORATION | 7 | $313 |
| Aimmune Therapeutics, Inc. | 16 | $282 |
| Novo Nordisk Inc | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| Ardelyx, Inc. | 4 | $90 |
| PFIZER INC. | 3 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $50 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, VOWST, Ozempic, ZENPEP.
Industry payments across CA — which companies pay providers there.
